ARS Pharmaceuticals, Inc. SEC filings SPRY
ARS Pharmaceuticals, Inc. has 549 filings in SEC EDGAR's recent list, going back to Apr 12, 2016. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Nov 25, 2024 | — |
| CORRESP | Letter to the SEC | Nov 18, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 7, 2024 | — |
| EFFECT | Filing | May 3, 2023 | — |
| CORRESP | Letter to the SEC | May 1, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 24, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 7, 2022 | — |
| CORRESP | Letter to the SEC | Sep 16, 2022 | — |
| PRER14A | Filing | Sep 16, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 9, 2022 | — |
| EFFECT | Filing | Jan 13, 2022 | — |
| CORRESP | Letter to the SEC | Jan 11, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 10, 2022 | — |
| EFFECT | Filing | Dec 3, 2020 | — |
| SEC STAFF LETTER | Filing | Dec 3, 2020 | — |
| CERT | Filing | Dec 3, 2020 | — |
| CORRESP | Letter to the SEC | Dec 1, 2020 | — |
| CORRESP | Letter to the SEC | Dec 1, 2020 | — |
| 8-A12B | Filing | Dec 1, 2020 | — |
| CORRESP | Letter to the SEC | Nov 30, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 27, 2020 | — |
| CORRESP | Letter to the SEC | Nov 18, 2020 | — |
| CORRESP | Letter to the SEC | Nov 10, 2020 | — |
| SEC STAFF LETTER | Filing | Oct 30, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 29, 2020 | — |
| D | Filing | Oct 6, 2020 | — |
| DRS | Filing | Oct 2, 2020 | — |
| D | Filing | Mar 19, 2020 | — |
| D | Filing | Sep 20, 2018 | — |
| D | Filing | Jan 8, 2018 | — |
| D/A | Filing | Feb 6, 2017 | — |
| D | Filing | Nov 30, 2016 | — |
| D | Filing | Apr 12, 2016 | — |
| D | Filing | Apr 12, 2016 | — |
Showing 34 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SPRY (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1671858
- Former names
- Silverback Therapeutics, Inc. (until Nov 8, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.